Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Community-acquired Bacterial Pneumonia”

103 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 103 results

Large-scale testing (Phase 3)Study completedNCT02531438
What this trial is testing

Omadacycline vs Moxifloxacin for the Treatment of CABP (EudraCT #2013-004071-13)

Who this might be right for
Bacterial PneumoniaCommunity-Acquired Infections
Paratek Pharmaceuticals Inc 774
Large-scale testing (Phase 3)Study completedNCT04779242
What this trial is testing

Omadacycline vs. Moxifloxacin for the Treatment of Community-Acquired Bacterial Pneumonia

Who this might be right for
Community-acquired PneumoniaBacterial Pneumonia
Paratek Pharmaceuticals Inc 670
Large-scale testing (Phase 3)Study completedNCT00035269
What this trial is testing

New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia)

Who this might be right for
Pneumonia, PneumococcalCommunity Acquired InfectionsGram-positive Bacterial Infections
Pfizer 230
Not applicableStudy completedNCT04652167
What this trial is testing

Diagnostic Accuracy of Infection Biomarkers in the Initial Investigation of Patients With Suspected Pneumonia

Who this might be right for
Pneumonia, Bacterial
University of Southern Denmark 411
Early research (Phase 1)Ended earlyNCT05629741
What this trial is testing

A 2-Part First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of CMTX-101

Who this might be right for
Community-acquired PneumoniaBacterial Pneumonia
Clarametyx Biosciences, Inc. 28
Not applicableEnded earlyNCT04280354
What this trial is testing

Molecular Biomarkers for Sepsis

Who this might be right for
SepsisSevere Community-acquired Pneumonia (sCAP)Infection, Bacterial
University Hospital, Basel, Switzerland 3
Large-scale testing (Phase 3)WithdrawnNCT02269644
What this trial is testing

A P3 Comparator Trial in Community Acquired Bacterial Pneumonia

Who this might be right for
Community Acquired Pneumonia
Durata Therapeutics Inc., an affiliate of Allergan plc
Not applicableStudy completedNCT02946775
What this trial is testing

Community Acquired Bacteremic Syndromes in Young Nigerian Children

Who this might be right for
Community-Acquired Infections
University of Nebraska 29,146
Not applicableStudy completedNCT03613636
What this trial is testing

Evaluation of Pathogenesis and Diagnosis of Mycoplasma Pneumoniae Community-acquired Pneumonia (CAP)

Who this might be right for
Childhood PneumoniaMycoplasma PneumoniaAntibody-secreting Cells+2 more
University Children's Hospital, Zurich 490
Large-scale testing (Phase 3)Looking for participantsNCT02735707
What this trial is testing

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Who this might be right for
Community-acquired Pneumonia, Influenza, COVID-19
UMC Utrecht 20,000
Post-approval studies (Phase 4)Study completedNCT00744263
What this trial is testing

Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults

Who this might be right for
Pneumonia, PneumococcalPneumococcal Infections13-valent Pneumococcal Vaccine
Pfizer 84,496
Large-scale testing (Phase 3)Study completedNCT00538694
What this trial is testing

Comparative Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia

Who this might be right for
Pneumonia, Bacterial
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Large-scale testing (Phase 3)Study completedNCT00466947
What this trial is testing

COMPAS (Clinical Otitis Media & Pneumonia Study): Pneumonia & Acute Otitis Media (AOM ) Efficacy Study of the Pneumococcal Conjugate Vaccine

Who this might be right for
Infections, Streptococcal
GlaxoSmithKline 23,802
Large-scale testing (Phase 3)Study completedNCT01371838
What this trial is testing

Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia in Asia

Who this might be right for
Community-Acquired Bacterial PneumoniaLung Infection of Individual Not Recently Hospitalized
Pfizer 848
Testing effectiveness (Phase 2)Study completedNCT01420744
What this trial is testing

Safety and Efficacy Study of BT086 to Evaluate Adjunctive Therapy in sCAP

Who this might be right for
Community Acquired Pneumonia
Biotest 160
Post-approval studies (Phase 4)Looking for participantsNCT06804096
What this trial is testing

Efficacy and Safety of Faropenem in Bangladeshi Adult Patients With Community-Acquired Bacterial Pneumonia (CABP)

Who this might be right for
Pneumonia, Community-AcquiredBacterial Pneumonia
Dr. Md. Alimur Reza 160
Not applicableStudy completedNCT05114161
What this trial is testing

Promoting Optimal Treatment for Community-acquired Pneumonia in the Emergency Room (PIONEER)

Who this might be right for
Community-acquired Pneumonia
Hamilton Health Sciences Corporation 162
Not applicableWithdrawnNCT00867841
What this trial is testing

A Polymerase Chain Reaction (PCR) - Based Method to Improve Antibiotic Prescribing for Pneumonia

Who this might be right for
Pneumonia
Children's Hospital of Eastern Ontario
Post-approval studies (Phase 4)Study completedNCT04089787
What this trial is testing

Shortened Antibiotic Treatment of 5 Days in Community-Acquired Pneumonia

Who this might be right for
Community-acquired Pneumonia
Thomas Benfield 395
Not applicableStudy completedNCT03908632
What this trial is testing

An Observational Study to Assess the Prevalence and Outcomes of Primary Pulmonary Coccidioidomycosis in Persons Aged > / = 14 Years Presenting With Community Acquired Pneumonia (CAP) in Endemic Areas (SAnds-PPC)

Who this might be right for
CoccidioidomycosisPneumonia
National Institute of Allergy and Infectious Diseases (NIAID) 651
Load More Results